Understanding the intricacies of HIF-1α’s role in neutrophil function may provide valuable insights for the development of novel therapeutic approaches targeting HIF-1α to mitigate inflammation and tissue damage in ischemic heart diseases. Here, HIF1A is linked to coronary artery disorder.